These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35381311)

  • 21. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
    Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
    J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
    Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
    Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel bilayer gastroretentive tablets based on hydrophobic polymers.
    Nguyen TT; Hwang KM; Kim SH; Park ES
    Int J Pharm; 2020 Jan; 574():118865. PubMed ID: 31765783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
    Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
    J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of nateglinide controlled release tablet containing erosion matrix tablet and multiple administration study in normal beagle dogs.
    Makino C; Sakai H; Okano A; Yabuki A
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):907-13. PubMed ID: 19721250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of added alkalizer and surfactant on dissolution and absorption of the potassium salt of a weakly basic poorly water-soluble drug.
    Mahjour M; Kesisoglou F; Cruanes M; Xu W; Zhang D; Maguire TJ; Rosen LA; Templeton AC; Kress MH
    J Pharm Sci; 2014 Jun; 103(6):1811-8. PubMed ID: 24788413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro/in vivo relationship of gabapentin from a sustained-release tablet formulation: a pharmacokinetic study in the beagle dog.
    Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Han SB; Lee DS; Park ES
    Arch Pharm Res; 2008 Jul; 31(7):911-7. PubMed ID: 18704335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
    Yan G; Li H; Zhang R; Ding D
    Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs.
    Kim KS; Jin SG; Mustapha O; Yousaf AM; Kim DW; Kim YH; Kim JO; Yong CS; Woo JS; Choi HG
    Int J Pharm; 2015 Jul; 490(1-2):273-80. PubMed ID: 26024820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroretentive bilayer film for sustained release of atorvastatin calcium and immediate release of amlodipine besylate: pharmaceutical, pharmacokinetic evaluation, and IVIVC.
    Porwal A; Dwivedi H; Pathak K
    Pharm Dev Technol; 2020 Apr; 25(4):416-431. PubMed ID: 31852330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
    Zahoor FD; Mader KT; Timmins P; Brown J; Sammon C
    Mol Pharm; 2020 Apr; 17(4):1090-1099. PubMed ID: 32069060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
    Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and In Vitro-In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease.
    Zhang C; Shao H; Han Z; Liu B; Feng J; Zhang J; Zhang W; Zhang K; Yang Q; Wu S
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.